I believe it will be a biggie,,,,
Imugene Advances to Phase 2 in Gastric Cancer Immuno-oncology Trial ----------------------------------------------------------------------------------------------------------------------------------------------------------- • Phase 1b study objectives met; all dose levels showed increased antibody levels in all patients • Phase 2 study on track to start early 2019 • Dose level confirmed for Phase 2 with no safety issues reported • Phase 2 manufacturing of HER-Vaxx completed • Topline Phase 1b results expected December 2018
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-121
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
